RE:Shake shake the trees!I added some more last week. $1.74 level.
iMHO.
the actual buy- in price will be somewhat irrelevant, should Onc get into the analyst range of $6ps to $15ps.
that said. Those predictions do not include anything at all fo4 the upcoming Goblet Panc results we are about to get in 2 weeks.
assuming they additional patients see the same 48% tumour reduction alongside the co therapy with Roche ( tecentriq), then Onc Pelareorep becomes a blockbuster drug.
SP?
pick a number.
So, while we whittle away, low volume +/- a few cents/ day.
The presentations 15th of November, could create a whole new world.
so far all the build up looks positive. They would not spend the time or $$ to come out with bad news.